Year : 2009 | Volume
: 34 | Issue : 1 | Page : 68--70
Modern practice era: The purpose of physician's sample
Sugam A Bhatnagar, Jagannath V Dixit
Department of PSM, Government Medical College and Hospital, C 3 Asawari, Aurangabad, Maharashtra, India
Sugam A Bhatnagar
C 3 Asawari, Jyoti Nagar, Aurangabad - 431 005, Maharashtra
|How to cite this article:|
Bhatnagar SA, Dixit JV. Modern practice era: The purpose of physician's sample.Indian J Community Med 2009;34:68-70
|How to cite this URL:|
Bhatnagar SA, Dixit JV. Modern practice era: The purpose of physician's sample. Indian J Community Med [serial online] 2009 [cited 2019 Sep 16 ];34:68-70
Available from: http://www.ijcm.org.in/text.asp?2009/34/1/68/45378
Physician practice has evolved by a quantum in the last 20 years in India. With the mushrooming of state-of-the-art hospitals and multi-specialty clinics, the number of conventional self drug-dispensing 'neighborhood' clinics has nose dived lately. The act of giving medications in 'Pudiyas' (tablets wrapped in paper or plastic envelopes) was more a routine than just a practice by these neighborhood clinics. Physicians used to provide patients with unlabelled medications from their clinics as well as there used to be insistence on the part of the patient for medication from the doctor himself.
This practice of self drug-dispensing has become rare also owing to bubbling of multiple 'Pharmacy Shops' in close vicinity of these hospitals.
All these factors have brought an evolution in the methods and principles of medical practice and patient care and thus limited the use of physician sample which brings us to ask a very newfangled query 'What is the purpose of physician's sample (PS)?'.
Just in the year of 2003, the pharmaceutical industry in the USA spent a staggering $16.4 billion  on distributing free samples through promotional face-to-face activities and as many as 78% American doctors accepted PS in the year 2007.  The physician's sample are free samples, though the cost of which are added to the drug formulation cost which is eventually borne by the patient. Thus, the patient becomes a victim of a practice which seems to serve limited function and provide little satisfactory reasoning. With advertising highly restricted in our country, this expenditure on a proportional basis may amount to a huge sum in our country as well.
The present study is conducted with the objective of finding out the purpose of PS as perceived by the three main stake holders: the physicians, medical representatives (MR) and the pharmaceutical company executives concerned with production of drugs and quality assurance.
Materials and Methods
In our attempt to understand the true purpose of PS in the context of modern practice era, we devised a 3 perspective study involving practicing doctors, medical representatives and executives of the pharmaceutical industry. The study was carried with the help of interview schedule in the 3 month period of June-July-August 2007. The interview schedule was pre-tested and then used.
Sample selection and survey design
The sample of doctors was chosen from the resource of the Indian Medical Association (IMA) member list of Aurangabad and out of the 384 members, 38 doctors were selected on the basis of systematic random sampling. The doctors identified were from different specialties including internal medicine, paediatics, orthopaedics, surgery, dermatology, obstetrics and gynaecology, ophthalmology, ENT, radiology, psychiatry and general practice. They were subjected to a one-to-one interview. The interview took about 20 minutes.
10 MR were randomly chosen on the basis of their departments and divisions. They were selected when they were visiting and meeting doctors from different medical specialties. It was carefully screened that the MR met the doctors for providing free samples only and not for any other incentive.
4 executives from 4 of the 8 prominent pharmaceutical companies were chosen randomly for interview. These included production managers, quality assurance managers and supply managers.
Characteristic qualitative analysis of the respondents was done after the completion of survey and collection of data from the sample. Responses of the interviewees are shown below in the tables [Table 1] and [Table 2] present the responses of interviewees.
Our data shows that the purpose of PS was more inadequate than the justification of its valid use. Suggesting that 76% doctors believed that main purpose of PS is to serve the poor patients, 86% of whom agreed that the purpose is not served effectively. While almost all the doctors used to get regular visits and PS, only 45% of the doctors accepted the PS. Most of the other 55% doctors believed that underutilization is the most important factor in their denial of acceptance. As many as three-quarters' of the doctors believed that the practice is ineffective in serving the purposes it ought to. Several of the interviewees highlighted that free samples are dependent on the 'pen power' or 'scalpel power' of the doctor in question. Interviewees strongly believed that when a seller whose basic objective beyond any shade of doubt is just to promote sales, becomes the educator, rationality is the first casualty.  This is amply evident in the study by Zweiffler et al, which states that patients with hypertension that are treated with free drug samples are less likely to have their hypertension controlled than are patients whose hypertension is treated by the physicians' free choice of drugs.,
Pharmaceutical Company managers in their interview suggested that the main purpose of the PS is to create awareness about the brand name. Many of them suggested that reception of feedback from the doctor on the performance of drug boosts their R and D and is important part of the Clinical Trial stage IV. On the contrary, only 1 out of the 4 managers interviewed believed that the practice is 'ethically skewed'. The exact manufacturing practices of PS could not be inquired but it was based on strategies of marketing and promotion, targeted mostly at doctors with higher 'pen power'.
An objection put forth by most MR was relating to staff's or doctor's habit of taking sample drugs home rather than giving to the patients.  They also believed that a national authority for screening and monitoring of promotional data would be effective in a large way to model ethically the system of provision of free samples. Though all the MR believed that there is wastage of the PS, 7 out of 10 believed it is serving the purpose and some sort of underutilization is inevitable. They suggested that utilization of more than 50% of the sample is an indicator of efficient use. On the other hand, 2 out of 10 MR suggested that most doctors do not accept PS and the practice will be out of fashion sooner than later, they also believed that PS is a waste of raw materials, efforts, and environment. More than 50% believed that the ideal way to utilize these samples is to organize camps or donate to trusts; they also believed sample utilization is more effective in government institutions than private clinics.
This conflicting multi-perspective approach has mainly arisen due to slow or probably no evolution in the practice of giving physician's sample (PS) while the principles of medical practice have changed substantially. We believe that this practice offers limited purpose in the modern medical practice scenario. On further critical analysis, we suggest that there should be a national debate among the stake holders including the patients to look into this matter as it is concerned directly with the pubic interests and money. Further rules and regulations should be established to prevent any unethical or unlawful way of business. An initiative taken by professional bodies of doctors, MR and consumers looking into information and modus operandi related to the distribution of PS would go a long way in preventing malpractices if any.
The authors are grateful to the President and the Secretary of the Aurangabad chapter of the Indian Medical Association, for their co-operation in conducting the study.
The authors would also like to extend thank you to the participating members of the study.
|1||Ben H. Pushing drugs: How medical marketing influences doctors and patients. Science News Online. Epub 2005;168:75. Available from: http://www.sciencenews.org/articles/20050730/bob10.asp.|
|2||Gupta S. Chief Medical Correspondent, CNN. Doctors and Drug Companies. Epub 2007 May 01 Tuesday. Available from: http://edition.cnn.com/HEALTH/blogs/paying.dr.gupta/archive/2007_04_29_archive.html.|
|3||Agrawal S. Medical Profession and the Pharmaceuticals: Indian Scenario. Indian Paediatrics 1998;35:641-5. Available from: http://www.indianpediatrics.net/july1998/july-641-645.htm|
|4||Zweifler J, Hughes S, Schafer S, Garcia B, Grasser A, Salazar L. Are sample medicines hurting the uninsured? J Am Board Fam Pract 2002;15:361-6. |
|5||Brody H. The Company We Keep: Why Physicians should refuse to see pharmaceutical representatives. Ann Fam Med 2005;3:82-5.|